Table 4.
Estimation of infectious WPs based on LODs on P0027 HBV genotype A, P0019 HCV genotype 1 and P0027 HIV-1 subtype C standard dilution panels based on the 50% LODs found on the BioQControl reference panels
| Virus | MID50 (virions) | WP ID-NAT (days) | WP MP6-NAT (days) | WP MP16-NAT (days) | WP MP24-NAT (days) |
|---|---|---|---|---|---|
| HBV | 1 | 18.1 | 25.5 | 28.7 | 30.1 |
| HCV | 1 | 2.5 | 3.7 | 4.3 | 4.6 |
| HIV-1 | 1 | 4.0 | 6.3 | 7.4 | 7.9 |
|
| |||||
| HBV | 3.16 | 13.8 | 21.2 | 24.4 | 25.8 |
| HCV | 3.16 | 1.8 | 3.0 | 3.6 | 3.8 |
| HIV-1 | 3.16 | 2.6 | 4.9 | 6.0 | 6.5 |
|
| |||||
| HIV-1 | 31.6 | 0.66 | 2.1 | 3.2 | 3.7 |
| Virus | MID50 (virions) | WP ID-NAT (days) | WP MP6-NAT (days) | WP MP16-NAT (days) | WP MP24 NAT (days) |
|---|---|---|---|---|---|
| HBV | 1 | 14.5 | 21.8 | 25.1 | 26.5 |
| HCV | 1 | 2.8 | 4.0 | 4.6 | 4.9 |
| HIV-1 | 1 | 3.7 | 6.0 | 7.1 | 7.6 |
|
| |||||
| HBV | 3.16 | 10.3 | 17.5 | 20.8 | 22.2 |
| HCV | 3.16 | 2.1 | 3.3 | 3.9 | 4.1 |
| HIV-1 | 3.16 | 2.4 | 4.6 | 5.7 | 6.2 |
|
| |||||
| HIV-1 | 31.6 | 0.56 | 1.9 | 2.9 | 3.4 |